Search for: "Sanofi-Aventis, U.S., Inc." Results 61 - 80 of 120
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jul 2011, 2:34 pm by Tom Lamb
"  (8/4/11, Health Canada MedEffect e-Notice) Multaq (dronedarone), Sanofi-aventis Canada Inc., must not be prescribed to patients with permanent atrial fibrillation. [read post]
10 Jul 2011, 11:29 pm by Gordon Johnson
The committee is seeking documents and information from Amphastar Pharmaceuticals, Momenta Pharmaceuticals, Siegfried USA Inc., Sagent Pharmaceutical, APP Pharmaceuticals, Sanofi Aventis, Drug Source Company LLC, Global Pharma Sourcing LLC, Pacific Rainbow International and Sandoz. [read post]
29 Jun 2011, 3:34 am by Marie Louise
Cipla (Spicy IP) Effexor (Venlafaxine) – US: Intellipharmaceutics announces settlement for its generic version of Effexor (GenericsWeb) Eloxatin (Oxaliplatin) – US: Patent infringement complaint in response to Para IV certification: Sanofi-Aventis U.S. [read post]
15 May 2011, 2:54 pm by FDABlog HPM
Karst –       Last week, the Federal Trade Commission (“FTC”) announced that the Commission’s Bureau of Competition (“Bureau”) sent letters (here, here, and here) to Sanofi-Aventis U.S. [read post]
10 May 2011, 4:24 pm by Aaron Barkoff
In a press release today, the Federal Trade Commission announced that it "has notified Sanofi-Aventis U.S. [read post]
27 Mar 2011, 6:28 pm
Jones Ward PLC attorney Larry Jones filed a lawsuit this week against pharmaceutical giant sanofi-aventis U.S., Inc. [read post]
25 Mar 2011, 8:26 am
This week Jones Ward PLC filed a lawsuit against sanofi-aventis U.S., Inc. on behalf of the Estate of Samuel Hunter. [read post]
25 Mar 2011, 8:26 am
This week Jones Ward PLC filed a lawsuit against sanofi-aventis U.S., Inc. on behalf of the Estate of Samuel Hunter. [read post]
15 Mar 2011, 3:52 pm by Mike
Judge Susan Illston recently granted summary judgment on a few claims but left others for trial in a massive pharmaceutical patent case between Sanofi-Aventis Deutchland GMBH (Sanofi, plaintiff), Genentech, Inc. [read post]
18 Feb 2011, 11:47 am by Sheppard Mullin
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
9 Jan 2011, 9:09 pm by Patent Docs
USA 1:11-cv-00018; filed January 6, 2011 in the District Court of Delaware • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
26 Dec 2010, 9:59 pm by Patent Docs
The appeal arose from a dispute between Sun and Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Aventis U.S. [read post]